The rating affirmation acknowledges KDMC’s favorable market position, relative size and scope of operations and solid liquidity position.
The outlook is negative, reflecting KDMC’s lack of a longer track record of sustainable improvement.
Moody’s also affirmed the “Baa2” rating on KDMC’s outstanding debt, affecting $235 million of bonds.
More articles on healthcare finance:
5 most-read finance stories: Week of Aug. 29-Sept. 2
Tulare Regional Medical Center will remain open after $55M bond measure fails to pass
Math errors, Medicaid changes cause reimbursement pressures for Massachusetts hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
